These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38881059)

  • 21. Comparison of haplo-SCT and chemotherapy for young adults with standard-risk Ph-negative acute lymphoblastic leukemia in CR1.
    Lv M; Jiang Q; Zhou DB; Hu Y; Liu DH; Wu DP; Wang JB; Jiang H; Wang J; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    J Hematol Oncol; 2020 May; 13(1):52. PubMed ID: 32414392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: current treatments and future perspectives.
    Yilmaz M; Kantarjian H; Ravandi-Kashani F; Short NJ; Jabbour E
    Clin Adv Hematol Oncol; 2018 Mar; 16(3):216-223. PubMed ID: 29742077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission.
    Cherrier-De Wilde S; Rack K; Vannuffel P; Delannoy A; Hagemeijer A
    Leukemia; 2003 Oct; 17(10):2046-8. PubMed ID: 14513056
    [No Abstract]   [Full Text] [Related]  

  • 24. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
    Nicolini FE; Basak GW; Kim DW; Olavarria E; Pinilla-Ibarz J; Apperley JF; Hughes T; Niederwieser D; Mauro MJ; Chuah C; Hochhaus A; Martinelli G; DerSarkissian M; Duh MS; McGarry LJ; Kantarjian HM; Cortes JE
    Cancer; 2017 Aug; 123(15):2875-2880. PubMed ID: 28387926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Philadelphia chromosome-positive acute lymphoblastic leukemia in children.
    Oki Y; Kishi Y; Kami M
    N Engl J Med; 2000 Oct; 343(14):1043; author reply 1043-4. PubMed ID: 11023396
    [No Abstract]   [Full Text] [Related]  

  • 26. Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Fielding AK
    Haematologica; 2010 Jan; 95(1):8-12. PubMed ID: 20065078
    [No Abstract]   [Full Text] [Related]  

  • 27. [Management of pH-positive acute lymphoblastic leukemia].
    Ohba R; Usui N
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():465-9. PubMed ID: 23134000
    [No Abstract]   [Full Text] [Related]  

  • 28. The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia.
    Rees MJ; Wu S; Mokoonlall M; Dix CHK; Bryant CE; D'Rozario J; Schwarer A; Grigg A; Tiong IS
    Leuk Lymphoma; 2021 Oct; 62(10):2531-2534. PubMed ID: 33899667
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Yanada M
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():479-82. PubMed ID: 17474451
    [No Abstract]   [Full Text] [Related]  

  • 30. Indications for allogeneic hematopoietic cell transplantation for adults with Philadelphia-chromosome negative acute lymphoblastic leukemia in first complete remission: all about MRD?
    Aldoss I; Pullarkat V
    Bone Marrow Transplant; 2019 Jan; 54(1):3-5. PubMed ID: 30446742
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of outcomes following autologous stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia during first complete remission.
    Kato H; Kawase T; Kako S; Mizuta S; Kurokawa M; Mori T; Ohashi K; Iwato K; Miyamura K; Hidaka M; Sakamaki H; Suzuki R; Morishima Y; Tanaka J;
    Haematologica; 2014 Nov; 99(11):e228-30. PubMed ID: 25015939
    [No Abstract]   [Full Text] [Related]  

  • 32. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
    DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy-free regimen: a new hope in Philadelphia-positive acute lymphoblastic leukemia.
    Saleh K; Chahine C; Khalife N
    Future Oncol; 2021 Apr; 17(11):1265-1267. PubMed ID: 33573414
    [No Abstract]   [Full Text] [Related]  

  • 34. Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients.
    Jain N; Lu X; Daver N; Thakral B; Wang SA; Konoplev S; Patel K; Kanagal-Shamanna R; Valentine M; Tang G; Pemmaraju N; Jorgensen J; Kebriaei P; Nunez CA; Wierda W; Jabbour E; Roberts KG; Mullighan CG; Kantarjian H; Konopleva M
    Haematologica; 2017 Dec; 102(12):e514-e517. PubMed ID: 28860345
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.
    Varda-Bloom N; Danylesko I; Shouval R; Eldror S; Lev A; Davidson J; Rosenthal E; Volchek Y; Shem-Tov N; Yerushalmi R; Shimoni A; Somech R; Nagler A
    Oncotarget; 2017 Jan; 8(1):418-429. PubMed ID: 27880933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imatinib for secondary Ph+ acute lymphoblastic leukemia induces response in concomitant GBM.
    De Vita S; De Matteis S; Laurenti L; Chiusolo P; Sorà F; Piccirillo N; Reddiconto G; Fiorini A; Leone G; Sica S
    Ann Oncol; 2006 Apr; 17(4):720-1. PubMed ID: 16263757
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
    Takeuchi J
    Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763
    [No Abstract]   [Full Text] [Related]  

  • 38. BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well?
    Andolina JR
    Acta Haematol; 2015; 134(2):69-70. PubMed ID: 25895547
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia.
    Ottmann OG; Larson RA; Kantarjian HM; le Coutre PD; Baccarani M; Hochhaus A; Kim DW; Fan X; Novick S; Giles FJ
    Leukemia; 2013 Jun; 27(6):1411-3. PubMed ID: 23138184
    [No Abstract]   [Full Text] [Related]  

  • 40. EIF3B Associates with Exacerbated Clinical Features, Poor Treatment Response and Survival in Adult Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Patients.
    Zhu F; Fu Y; He X
    Technol Cancer Res Treat; 2021; 20():15330338211041464. PubMed ID: 34617851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.